Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,096.82
-0.1118-0.01%
Number of Gainers:505
Number of Losers:488
Number of Flat:28
PE:- -
High:2,100.64
Open:2,096.97
Low:2,093.04
Close:2,096.93
Volume:4.96B
Turnover:635.07B
Market Cap:97.53T
Float Cap:91.30T

Loading ...

Healthcare Stocks Among Top Losers

Dow Jones
·
Oct 02

UWM Holdings Registers for Resale up to 330,000,000 Shares Issuable on Warrant Exercise

Reuters
·
Oct 02

Paychex Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 02

Biogen Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Oct 02

Primer: Tesla (TSLA US) - Oct 2026

Smartkarma
·
Oct 02

Hertz Names Robert Davis, Nils Larsen, Adam Zirkin to Board After Three Director Resignations

Reuters
·
Oct 02

NetApp Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 02

Keurig Dr Pepper Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 02

Energy Shares Rise as Oil Rally Resumes

Dow Jones
·
Oct 02

PBF Energy: Unit Enters Amended and Restated Revolving Credit Agreement on Sept 30, 2026 - SEC Filing

THOMSON REUTERS
·
Oct 02

PBF Energy: 2026 Revolving Loan Has Maximum Commitment of $4 Bln, Maturity Sept 30, 2031 - SEC Filing

THOMSON REUTERS
·
Oct 02

Waters Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Oct 02

Credo Technology CTO Cheng Chi Fung Sells USD 5.03 Million in Common Shares

Reuters
·
Oct 02

Goodyear Tire & Rubber to Close Chemical Facilities in New York, Texas

MT Newswires Live
·
Oct 02

GitLab CEO William Staples Acquires 2,677 Common Shares Worth $124,789.74

Reuters
·
Oct 02

W.W. Grainger Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 02

Fastenal Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 02

Nike Stock Falls on Disappointing Full-Year Forecast

Dow Jones
·
Oct 02

Elutia Receives $8 Million Payment from Boston Scientific; Company NOW Fully Funded into 2029

THOMSON REUTERS
·
Oct 02

Elutia: Continues to Expect Favorable FDA Clearance Decision for NXT-41X in H1 2027

THOMSON REUTERS
·
Oct 02